TMCLIFE | TMC LIFE SCIENCES BERHAD
0.455 (1.11%)
T-O (am): 0.000 (08:59:00)
Last updated: 16:58
TMCLIFE Fundamental Trend
FCON: | Sharpe Ratio: | LTS:
TMCLIFE Quarter Reports
Customize
Select columns required and click "Update" to save your preferences
TMCLIFE Historical Dividends
TMCLIFE Financial Ratios
| EPS | 0.75 sen |
| Trailing PE (Sector Median: 23.2) | 60.8 |
| PEG | 60.8 |
| Altman Z | 0.9 |
| Beaver | 0.213 |
| Current Ratio | 2.81 |
| Debt-Equity (DE) Ratio | 0.35 |
| FCF Yield | 5.95 % |
| Revenue QoQ | -1.88 % |
| Revenue YoY | -14.24% |
| Profit QoQ | -132.25 % |
| Profit YoY | -106.52 % |
| Profit Margin (Sector Median: 6.6) | 4.02 % |
| ROE (ROIC: 4.92) | 5.96 % |
| Dividend Per Share (DPS) | 2.22 sen |
| Dividend Yield (DY) | 4.88 % |
TMCLIFE Adjusted Financial Ratios
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
| EPS | |
| Trailing PE (Sector Median: 23.2) | |
| Profit QoQ | |
| Profit YoY | |
| Profit Margin (Sector Median: 6.6) | |
| ROE (ROIC: 4.94) | |
| Altman Z |
TMCLIFE Fair Value
Weighted Average Fair Value:
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 0.49 |
| Consistent QR FV |
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | -0.95 |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 319.15 |
| Expected Revenue (M) | 2690.98 |
| Expected Growth (%) | 43.0 |
TMCLIFE Directors Share Purchases (Beta)
No transaction in the last 2 months.
TMCLIFE Summary
Market Cap: 789 M.
Market Cap Class: Middlers
Number of Shares: 1736 M.
Adjusted Float: 100%.
Stock highly correlated with
GENTING (95%)
SMTRACK (94%)
GENM (93%)
MAA (93%)
TMC Life Sciences Berhad, through its subsidiaries, provides a range of fertility treatment services in Malaysia. It is engaged in the development, marketing, management of healthcare programs; provision of storage of cord blood and adult stem cells, stem cell therapy, and application services. It operates women's clinic and medical center; and provides gynecological and fertility problem management, as well as consultancy, and research and development services. The company operates TMC fertility centers. The company was founded in 1994 and is headquartered in Petaling Jaya, Malaysia.
Sectors: Trading & Services, Healthcare, Health Care Providers, Penny Stocks
Code: 0101
Website: http://www.tmclife.com/
Related Links: Bursa | Annual Report | Announcement
Warrant Info:
No warrants listed